Helen C. Adams Immix Biopharma, Inc. (IMMX) insider trading activity

IMMX Quotes by TradingView

Helen C. Adams is Director of Immix Biopharma, Inc.. Currently has a direct ownership of 174,754 shares of IMMX, which is worth approximately $316,304. The most recent transaction as insider was on May 20, 2024, when has been sold 74,241 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K
0% 3M change
1244.26% 12M change
Total Value Held $316,304

Helen C. Adams Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
BUY
Grant, award, or other acquisition
-
74,241 Added 29.82%
174,754 Common Stock
May 15 2024
BUY
Grant, award, or other acquisition
-
87,740 Added 46.55%
100,740 Common Stock
Sep 12 2023
BUY
Open market or private purchase
$38,480 $2.96 p/Share
13,000 Added 50.0%
13,000 Common Stock

Also insider at

RXDX
Prometheus Biosciences, Inc. Healthcare
Director
HCA

Helen C. Adams

Director
Los Angeles, CA

Track Institutional and Insider Activities on IMMX

Follow Immix Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMMX shares.

Notify only if

Insider Trading

Get notified when an Immix Biopharma, Inc. insider buys or sells IMMX shares.

Notify only if

News

Receive news related to Immix Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMMX